Vitality, viability, long-term clonogenic survival, cytotoxicity, cytostasis and lethality: what do they mean when testing new investigational oncology drugs?
Crossref DOI link: https://doi.org/10.1007/s12672-023-00857-2
Published Online: 2024-01-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Forgie, Benjamin N.
Prakash, Rewati
Goyeneche, Alicia A.
Telleria, Carlos M.
Text and Data Mining valid from 2024-01-05
Version of Record valid from 2024-01-05
Article History
Received: 19 October 2023
Accepted: 29 December 2023
First Online: 5 January 2024
Declarations
:
: The authors declare no competing interests.